8
Participants
Start Date
February 28, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2011
BIM 23A760
BIM 23A760 is a solution at a concentration of 5 mg/mL ready for subcutaneous injection. BIM 23A760 dose of 1, 2, 4, 6 and 8 mg can be given to the patient according to a dose escalation and titration process. Patients will receive 24 weekly injections of BIM 23A760 during the treatment period. Patients eligible to continue the extension phase will be administered BIM 23A760 for further 52 weekly injections.
UZ Antwerpen, Edegem
UZ GAsthuisberg, Leuven
Erasmus MC, Rotterdam
UZ Gent, Ghent
UMCG, Groningen
Institut Paoli Calmette, Marseille
Charite Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin
Ospedale San Martino, Genova
Istituti Ospitalieri di Cremona, Cremona
Hospital Universitario Ramon y Cajal, Madrid
Hospital 12 de Octubre, Madrid
Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna
AO Universitaria Policlinico di Modena, Modena
Centre René Gauducheau, Nantes
Rabin Medical Center, Petah Tikva
Universitätsmedizin Mainz, Mainz
Universitätsklinikum Heidelberg, Heidelberg
Donetsk National Medical University named after M. Gorkiy, Donetsk Regional Antitumor Center, Donetsk
Narodny onkologicky ustav, Bratislava
Uzhgorod national university, Postgraduate faculty, Uzhgorod Central City Clinical Hospital, Uzhhorod
Hadassah Medical Organization, Jerusalem
"Non-state Institution of Public health Central Clinical hospital # 1, public corporation Russian railways", Moscow
St-Petersburg State Medical University named after academician Pavlov I.P., Saint Petersburg
St-Petersburg State Institution of Public Health City Clinical Oncology dispensary, Saint Petersburg
Tula Regional Oncology Dispensary, Tula
Voronezh Regional Clinical Oncology Dispensary, Voronezh
Republican Clinical Oncology dispensary of the Ministry of Health of Republic of Tatarstan, Kazan'
Altay Regional Oncology dispensary, Barnaul
University Hospital, Internal Medicine - Oncology, Vienna
Fakultní nemocnice Hradec Králové, Hradec Králové
Fakultní nemocnice Olomouc, Olomouc
Fakultní nemocnice Na Bulovce, Ústav radiační onkologie, Prague
Helsinki Central University Hospital, Helsinki
Turku University Hospital, Turku
Service de Gastroentérologie, Clichy
Unité de Gastro-Entérologie, Villejuif
St James's Hospital, Dublin
Unité d'Oncologie Médicale, Lyon
Ospedale S.Maria della Misericordia, Perugia
"Università degli Studi di Roma La Sapienza, II Facoltà di Medicina e Chirurgia, Ospedale Sant'Andrea", Roma
Latvian Oncology centre of Riga Eastern Clinical University Hospital, Riga
Vidzemes Hospital, Valmiera
Centrum Onkologii Instytut im.M. Sklodowskiej-Curie oddzial w Gliwicach, Gliwice
Szpital Uniwersytecki w Krakowie, Krakow
Instytut im Marii Sklodowskiej Curie, Warsaw
Samodzielny Publiczny Szpital Kliniczny nr 1, Wroclaw, 50-367
Martinska fakultna nemocnice, Martin
Hospital Universitario Son Dureta, Palma de Mallorca
Akademiska Hospital, Dept of Oncology & Endocrinology, Uppsala
University Hospital Aintree, Liverpool
St Bartholomew's Hospital, London
Royal Free Hospital, London
Christie Hospital and Holt Radium Institute, Manchester
Royal Preston Hospital, Sharoe Green Lane, Lancashire, Preston
Lead Sponsor
Ipsen
INDUSTRY